Press-release for stocks for novartis ag for gnmsf

Genmab Announces Financial Results for the First Nine Months of 2023
Published: 2023-11-07 (Crawled : 16:00) - globenewswire.com
GNMSF | $290.38 3.83% 220

Health Technology

| -0.26% | O: 0.39% H: 4.92% C: 1.52%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| 0.97% | O: 0.24% H: 0.18% C: 0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -2.48% | O: 0.18% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 17.36% | O: -0.28% H: 0.0% C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K

Health Technology

| -0.52% | O: 0.24% H: 3.44% C: 2.07%
BNTX | $86.82 0.75% 0.75% 1.6M

Health Technology

| -12.94% | O: -0.35% H: 3.09% C: 3.03%
financial results

Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published: 2023-05-15 (Crawled : 17:00) - prnewswire.com
GNMSF | $290.38 3.83% 220

Health Technology

| -32.3% | O: 0.24% H: 0.66% C: 0.66%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 7.89% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M

Health Technology

| -19.17% | O: 0.61% H: 0.3% C: 0.24%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -8.51% | O: 0.2% H: 0.13% C: -0.22%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| 8.81% | O: 0.27% H: 0.6% C: 0.41%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -14.4% | O: 0.38% H: 0.0% C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K

Health Technology

| -31.16% | O: 0.38% H: 0.91% C: 0.69%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| 15.45% | O: 0.14% H: 0.28% C: 0.11%
report cancer global therapy growth market

Genmab Announces Financial Results for the First Quarter of 2023
Published: 2023-05-10 (Crawled : 14:20) - globenewswire.com
GNMSF | $290.38 3.83% 220

Health Technology

| -28.67% | O: 0.92% H: 0.54% C: -0.64%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 7.53% | O: -1.24% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -9.88% | O: -1.03% H: 0.26% C: 0.01%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.16% | O: 0.09% H: 0.48% C: 0.28%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 13.34% | O: -0.21% H: 0.32% C: -0.07%
GMAB | $28.72 1.38% 1.36% 360K

Health Technology

| -27.49% | O: 0.15% H: 2.12% C: 1.79%
BNTX | $86.82 0.75% 0.75% 1.6M

Health Technology

| -17.07% | O: -1.6% H: 1.64% C: -0.39%
financial results

Genmab Publishes 2022 Annual Report
Published: 2023-02-22 (Crawled : 17:00) - globenewswire.com
GNMSF | $290.38 3.83% 220

Health Technology

| -27.17% | O: -0.51% H: 1.17% C: -0.9%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| 8.76% | O: 0.98% H: 0.03% C: -1.06%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -6.39% | O: 0.32% H: 0.22% C: -0.45%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 9.48% | O: -0.66% H: 0.76% C: -0.22%
HALO M | $38.64 2.2% 2.15% 1.3M

Health Technology

| -22.19% | O: -1.33% H: 4.88% C: 2.2%
GMAB | $28.72 1.38% 1.36% 360K

Health Technology

| -26.9% | O: -0.53% H: 0.32% C: -2.74%
report

Cancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector
Published: 2022-11-04 (Crawled : 18:00) - prnewswire.com
GNMSF | $290.38 3.83% 220

Health Technology

| -28.27% | O: -2.57% H: 3.43% C: 2.04%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 41.88% | O: 2.28% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| 17.39% | O: 1.13% H: 0.63% C: 0.53%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -12.95% | O: 0.38% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| 21.04% | O: 1.25% H: 0.03% C: -0.78%
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 100.82% | O: 0.97% H: 0.18% C: -2.13%
BMY | $48.93 1.3% 0.0% 10M

Health Technology

| -37.65% | O: 0.42% H: 0.59% C: -0.04%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 15.23% | O: 0.64% H: 0.16% C: -0.05%
GMAB | $28.72 1.38% 1.36% 360K

Health Technology

| -27.06% | O: 0.58% H: 0.93% C: 0.93%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| 1.15% | O: -1.48% H: 2.81% C: 2.71%
report cancer market

Genmab Announces Financial Results for the First Half of 2022
Published: 2022-08-10 (Crawled : 15:20) - globenewswire.com
GNMSF | $290.38 3.83% 220

Health Technology

| -18.7% | O: -0.39% H: 5.07% C: -0.05%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| 8.27% | O: 1.0% H: 0.01% C: -0.67%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -13.32% | O: 0.3% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 18.65% | O: 0.47% H: 0.11% C: 0.02%
GMAB | $28.72 1.38% 1.36% 360K

Health Technology

| -18.3% | O: 2.33% H: 0.64% C: -0.72%

Genmab Announces Financial Results for the First Quarter of 2022
Published: 2022-05-11 (Crawled : 15:20) - globenewswire.com
GNMSF | $290.38 3.83% 220

Health Technology

| -2.38% | O: -0.51% H: 2.39% C: -0.57%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 33.69% | O: 0.81% H: 0.0% C: -0.09%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| 11.63% | O: 0.27% H: 1.2% C: -0.85%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -17.21% | O: -0.87% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 9.94% | O: 0.21% H: 0.0% C: 0.0%
HALO M | $38.64 2.2% 2.15% 1.3M

Health Technology

| 1.15% | O: 0.94% H: 2.18% C: 0.05%
GMAB | $28.72 1.38% 1.36% 360K

Health Technology

| -2.51% | O: -0.54% H: 0.96% C: -4.44%

Worldwide T-cell Lymphoma Industry to 2028 - Featuring Genmab, Seagen and GlaxoSmithKline Among Others
Published: 2022-04-28 (Crawled : 21:00) - prnewswire.com
GNMSF | $290.38 3.83% 220

Health Technology

| -18.56% | O: 2.93% H: 1.47% C: 1.33%
GLAXF | News | $20.2 -14.18% 510

Health Technology

| -27.34% | O: -0.45% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 24.5% | O: -1.05% H: 0.0% C: -0.99%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| 5.94% | O: 0.19% H: 0.59% C: -1.36%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| -12.0% | O: 0.89% H: 0.0% C: 0.0%
BMY | $48.93 1.3% 0.0% 10M

Health Technology

| -36.07% | O: -3.61% H: 3.02% C: 2.02%
BHC | $8.69 1.05% 0.0% 2.9M

Health Technology

| -55.98% | O: -1.67% H: 0.0% C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K

Health Technology

| -18.16% | O: 1.4% H: 0.82% C: -1.07%
t-cell

Worldwide Drug Delivery Industry to 2027 - Growing Focus Towards Home Care and Self-Administration Presents Opportunities
Published: 2022-02-23 (Crawled : 18:00) - prnewswire.com
GNMSF | $290.38 3.83% 220

Health Technology

| -7.01% | O: 5.23% H: 0.0% C: -0.34%
GLAXF | News | $20.2 -14.18% 510

Health Technology

| -3.63% | O: -0.48% H: 3.79% C: 3.12%
AZNCF | News | $138.24 -4.19% 800

Health Technology

| 13.22% | O: 1.68% H: 0.0% C: -1.1%
WST | $372.04 -1.4% 0.0% 440K

Health Technology

| 0.79% | O: 0.24% H: 0.24% C: -3.38%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| 9.94% | O: 1.82% H: 0.07% C: -1.0%
MDT | $79.48 0.37% -0.29% 6.7M

Health Technology

| -23.37% | O: 0.5% H: 0.25% C: -1.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.21% | O: 0.23% H: 0.7% C: -0.18%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| -6.89% | O: 1.9% H: 0.07% C: -0.87%
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 203.73% | O: 0.59% H: 0.89% C: -0.93%
BDX | $234.12 0.42% 0.0% 1.3M

Health Technology

| -11.37% | O: 0.22% H: 1.9% C: 1.48%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 14.32% | O: 0.45% H: 1.46% C: 0.37%
MMM | $92.27 0.86% -0.18% 3.6M

Producer Manufacturing

| -37.12% | O: 0.0% H: 0.4% C: -1.61%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -11.1% | O: 2.09% H: 0.08% C: -1.22%
GMAB | $28.72 1.38% 1.36% 360K

Health Technology

| -7.87% | O: 1.06% H: 0.0% C: -1.67%
AZN | News | $68.56 0.29% 0.29% 4.7M

Health Technology

| 12.73% | O: 1.43% H: 0.0% C: -1.85%
ATRS | $5.59 0.0%

Health Technology

| 62.03% | O: 0.29% H: 0.87% C: -2.6%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| 21.46% | O: 0.57% H: 0.48% C: -0.75%
drug liver growing drug delivery

Genmab Announces Financial Results for the First Nine Months of 2021
Published: 2021-11-10 (Crawled : 17:00) - globenewswire.com
GNMSF | $290.38 3.83% 220

Health Technology